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Background: Detection of microcalcifications on mammograms indicates the presence of breast lesion,
and the shapes of the microcalcifications as seen by conventional mammography correlates with the
probability of malignancy. This preliminary study evaluated the 3D shape of breast microcalcifications using
micro-computed tomography (micro-CT) and compared the findings with those obtained using
anatomopathological analysis.
Methods: The study analyzed breast biopsy samples from 11 women with findings of suspicious
microcalcifications on routine mammograms. The samples were imaged using a micro-CT (SkyScan 1076) at a
resolution of 35 μm. Images were reconstructed using filtered back-projection and analyzed in 3D using
surface rendering. The samples were subsequently analyzed by the pathology service. Reconstructed 3D images
were compared with the corresponding histological slices.
Results: Anatomopathological analysis showed that 5 of 11 patients had ductal breast carcinoma in situ. One patient
was diagnosed with invasive ductal carcinoma.
Individual object analysis was performed on 597 microcalcifications. Malignant microcalcifications tended to be thinner
and to have a smaller volume and surface area, while their surface area-to-volume ratio was greater than that of benign
microcalcifications. The structure model index values were the same for malignant and benign microcalcifications.
Conclusions: This is the first study to use micro-CT for quantitative 3D analysis of microcalcifications. This
high-resolution imaging technique will be valuable for gaining a greater understanding of the morphologic
characteristics of malignant and benign microcalcifications. The presence of many small microcalcifications can
be an indication of malignancy. For the larger microcalcifications, 3D parameters confirmed the more irregular shape of
malignant microcalcifications.
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Breast cancer is the most common cancer among women
worldwide [1] and ranks second in cancer-related deaths
after colon cancer [2]. Early detection of suspicious lesions
is thus crucial for the prognosis of the patient. Since
Salomon’s radiographs of mastectomy specimens in 1913
[3], it has been known that microcalcifications are associ-
ated with breast cancer [4]. Gershon-Cohen et al. [5] were
the first to report that the irregular, clustered appearance* Correspondence: inneke.willekens@gmail.com
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Using radiology, Lanyi et al. [6] classified 5641 micro-
calcifications according to their shape, categorizing them
as punctate, bean-shaped, linear, or branching. In 95%
of cases, at least two of these configurations are identified
simultaneously within individual clusters of microcalcifica-
tions (polymorphy).
State-of-the-art mammography is very sensitive in terms
of detecting calcifications. However, calcifications can
indicate benign or malignant lesions, leading to a large
number of false-positive mammograms and a relatively
low true-positive biopsy rate [7]. Since mammographyal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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2D projection image of a 3D object. Consequently, super-
position can result in underestimation of the number of
microcalcifications. This can be overcome by 3D breast
imaging techniques, such as breast computed tomography
(CT) [8]. However, the resolution of breast CT is too low
to resolve the 3D shape of microcalcifications.
The shape of microcalcifications is a major criterion
for distinguishing malignant versus benign tissue. Thin
linear, curvilinear, and branching shapes suggest malig-
nancy, while round or oval shapes suggest benign lesions
[9]. Clinical studies show that the shape of a microcalcifi-
cation cluster and the spatial distribution of individual
microcalcifications within it are important indicators of
malignancy [10]. Note that in these studies, the microcal-
cification shape has typically been assessed using two 2D
mammographic views.
The only way to determine the true shape of a 3D object
is to use a 3D imaging technique. Some microcalcifications
identified on mammograms have malignant characteristics,
while others are non-specific. Thus, biopsy is required to
establish a diagnosis. In an attempt to reduce the number
of false-positives and unnecessary biopsies generated by
screening mammography, radiologists have tried to
define criteria that identify suspicious lesions and that
help evaluate microcalcifications using properties such
as microcalcification shape, size, clustering, location, and
density [11]. Mammographic features that are commonly
associated with malignancy include changes from a previ-
ous mammogram, distortion of the surrounding tissue
architecture, association with less-dense tissue and calcifi-
cations, and the presence of more than ten calcifications
in the lesion. The radiographic indications for breast
biopsy include soft tissue lesion without calcifications,
soft tissue lesion with calcifications, and a focus of cal-
cifications without an associated soft tissue lesion [12].
Some investigators suggest that all patients with isolated
microcalcification clusters at preoperative mammographic
examination should have a localization biopsy due to the
relatively high rate of malignant disease [13]. Because
of the low radiographic contrast and the small size of
the calcifications, methods have been sought that improve
the detection of microcalcifications in mammographic
images. A number of computer-assisted diagnostic (CAD)
methods that use characteristics such as microcalcification
size, shape, and distribution have been introduced to
increase the accuracy of mammographic diagnosis [14-19].
Breast CT and tomosynthesis are newly developed breast
imaging techniques, but they are still under investigation
and currently are not commonly used in diagnostic im-
aging. These new techniques may outperform breast
mammography for microcalcification detection [8], although
they may not be better than mammography because of
their spatial resolution. On the other hand, breast CToffers the advantage of three-dimensional anatomic de-
tail, plus it eliminates superimposition of glandular tis-
sues. However, in one study, screen-film mammography
outperformed CT for visualization of microcalcifications
[20] due to its higher spatial resolution. Other imaging
techniques that have been explored for breast cancer
detection included scintimammography [21], positron
emission tomography [22], optical imaging [23], and
microwave imaging [24]. Each approach has advantages,
but so far, none have been able to compete with mam-
mography as a screening modality [25].
The standard of care is routine mammography with
additional ultrasound in glandular breasts or additional
MRI. Taking a stereotactic core biopsy of indeterminate
or suspicious breast calcifications using vacuum-assisted
needles is a common practice. Radiography of these core
samples is necessary to document the success of the
procedure in extracting some of the target microcalci-
fications [26]. Afterwards, the biopsies are analyzed
anatomopathologically. The pathologist tries to differen-
tiate between benign and malignant tissue and, according
to the cell type, determines the final diagnosis. Nishide
et al. [27] reported that the resolution and contrast of
micro-focus CT imaging is comparable to that of patho-
logical images. Furthermore, microcalcifications were
more clearly detected in micro-focus CT imaging than
on the specimen radiographs.
In this study we used X-ray micro-computed tomography
(micro-CT) to learn more about the actual 3D shape of
microcalcifications in breast tissue. X-ray micro-CT is a
non-invasive high-resolution imaging method that has
been used primarily for bone imaging studies and material
analysis. Micro-CT is also effective for contrast-enhanced
soft tissue imaging [28,29]. This technique is increasingly
used in a preclinical setting as an in vitro imaging method
for analyzing tissue specimens and as an in vivo imaging
method for evaluating small animals [30,31]. A literature
search returned just one study [32] that used micro-CT to
look at breast biopsies from 16 patients. However, that
study focused on texture analysis rather than on shape. A
second study used micro-CT to examine the structural
and anatomic features of breast cancer specimens for
intraoperative assessments [33,34].
The aims of this preliminary study were to evaluate
the shape and number of breast microcalcifications using
high-resolution X-ray micro-CT and to compare the
findings with those obtained using radiography to analyze
the breast specimens. The core samples containing micro-
calcifications were scanned, analyzed, and compared with
the results of anatomopathological analysis. Although
the sample size in this preliminary study was small (596
microcalcifications, 11 patients), it analyzes the relation-
ship of the 3D shape of individual microcalcifications to
malignancy based on high-resolution images.
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Patient selection
In Belgium, women older than 45 years can have a routine
mammography performed every 2 years. A radiologist who
detects suspicious microcalcifications on a routine mam-
mogram may decide to do a biopsy. The shape, size,
clustering, location, and density of the microcalcifications
are used to determine whether the findings are suspicious.
Note that a microcalcification is defined as a calcifica-
tion smaller than 1 mm; larger calcifications are termed
macrocalcifications [35].
This study included the biopsy specimens of 11 women
(age range, 46–78 years; mean age, 55 years) with suspi-
cious microcalcifications on mammograms. The women
were consecutive patients. The ethics committee at the
university hospital (Commissie Medische Ethiek) approved
the study. All patients provided informed written consent,
which included consent for participation in the study and
consent to publish the findings.
Breast biopsy
Biopsies were performed by the Department of Radiology
at the university hospital by an experienced mammo-
grapher. Minimally invasive vacuum-assisted stereotactic
breast biopsies were performed using the Mammotome
Biopsy System [Ethicon Endo-Surgery (EES), Inc., Johnson
& Johnson, Langhorne PA, USA] under local anesthesia.
The extracted samples had a diameter of 3 mm and a
length of 23 mm and were put in a tube with formalin.
Multiple samples (range, 8–21; mean number, 14) were
taken from all 11 patients.
X-ray Micro-CT Imaging
Each biopsy sample, in a tube with formalin, was scanned
by micro-CT. Imaging was completed using a SkyScan
1076, an in vivo high-resolution X-ray micro-CT system
with a rotating source-detector pair. This type of scanner
has a fixed sample holder and was chosen to avoid move-
ment of the biopsy samples, which were kept in liquid
during scanning. The tubes containing tissue and formalin
were placed on the isocenter of the scanner bed and stabi-
lized using styrofoam.
The system consisted of a sealed 10-W micro-focus X-ray
source with a 5-μm focal spot and a tungsten target that
generates a broad polychromatic spectrum. To obtain
optimal contrast in the breast biopsies, lower X-ray energies
were selected by limiting the spectrum to 60 kV without
hardware filtering, which would eliminate the soft X-rays
from the spectrum. The large format X-ray detector
(4000 x 2300) consisted of a gadolinium powder scintilla-
tor optically coupled with a tapered fiber to a cooled CCD
chip. The projection images were taken every 0.5° and
covered a 180° view with an exposure time of 1.8 sec. The
total scanning time for each sample was 24 minutes. Theprojection images were resized in order to improve the
signal-to-noise ratio, resulting in a voxel size of 35 μm.
The reconstruction was performed using a modified
Feldkamp cone-beam algorithm (NRecon, SkyScan/Bruker
microCT, Kontich, Belgium) to return a stack of 2D cross-
sectional images.
Image analysis
The stack of micro-CT images was analyzed using the
SkyScan analysis software package CTAn and 3D Calculator
[36]. The analysis consisted of 3 steps: (1) segmentation of
the microcalcifications from the background; (2) calcula-
tion of morphological parameters; and (3) generation of
3D models for visual inspection.
Segmentation was improved by using an automated local
thresholding technique that was described by Waarsing
et al. [36]. After segmentation, the following structural
parameters were calculated for each segmented micro-
calcification of each patient: object volume (Obj.V), object
surface (Obj.S), object surface/volume ratio (Obj.S/Obj.V),
structure thickness (St.Th), structure model index (SMI),
and the number of objects (Obj.N). The 3D volume was
calculated based on the marching cubes model [37]. The
Obj.S/Obj.V provides a measure of the smoothness of the
particles. The St.Th, which was computed using a local
sphere-fitting method [38], is a 3D measure of the average
thickness of the microcalcifications. The SMI, a topo-
logical index, was calculated using differential analysis of
the triangulated surface of the structure, which gives an
estimate of the ratio of the number of plates to the num-
ber of rods that make up the 3D structure [39]). The SMI
values range from 0 to 4, with 0 indicating an ideal plate-
like structure, 3 an ideal rod-like structure, and 4 an ideal
sphere. Intermediate values signify a mixed structure.
The structural parameters were first averaged over all
microcalcifications per subject and compared between
the benign and malignant group. Next, the individual
microcalcifications associated with benign versus malig-
nant lesions were analyzed. One object segmented in
the samples from subject “Benign 2” was excluded
from the analysis as its maximum diameter exceeded
1 mm and the object therefore did not qualify as a
microcalcification [35].
Surface-rendered 3D models were made from the seg-
mented datasets for visual inspection using CTAn/CTVol
(SkyScan/Bruker microCT).
Specimen radiography
The specimens were radiographed using a mammography
system (GE Healthcare Senographe DS), 100-μm detector
element at 25 kVp with a Mo anode-Mo filter combination.
The beam quality was equal to 0.323-mm Al equivalent.
These images were used to identify biopsy samples with
and without microcalcifications.
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each with 5 to 15 years of experience, counted the number
of microcalcifications in 2 reading sessions that were
separated by an interval of 3 months to eliminate learning
effects.
Statistical analysis
The data were analyzed using IBM SPSS-Statistics version
20. Because of the low number of samples (5 benign, 6
malignant), non-parametric tests were used to compare
the morphological parameters at the subject level between
the two groups. The difference in the detection of micro-
calcifications by expert analysis versus micro-CT was
assessed by the Wilcoxon signed-rank test (asymptomatic
method). For the analysis of morphological parameters
at the microcalcification level (414 microcalcifications
associated with malignant lesions and 183 associated
with benign lesions), the normality of the data was tested
using the one-sample Kolmogorov-Smirnov test. For
normally distributed data, the independent sample t-test
was used to compare group averages; otherwise, the
Mann–Whitney U test was used. The significance level in
all tests was set to 0.05.
Results
Anatomopathological analysis demonstrated that 5 of the
11 patients had ductal breast carcinoma in situ (DCIS). Of
these, one patient had lower grade DCIS and 4 patients
had high grade DCIS. Another patient was diagnosed with
invasive ductal carcinoma.
The diagnoses of the patients with benign microcalcifica-
tions were fibrous breast tissue, benign fibroadenoma,
fibrocystic disease, Reclus disease, and fibroadenoid hyper-
plasia. Table 1 summarizes the anatomopathological resultsTable 1 Overview of the anatomopathological analysis and th
identified by X-ray micro-CT analysis
Cases Anatomopathological analysis
Benign 1 Fibrous breast tissue with benign calcification
Benign 2 Calcified benign fibro adenoma + fybrocystic mastopathy
Benign 3 Fybrocystic disease
Benign 4 Disease of Reclus
Benign 5 Fibro adenoid hyperplasia
Malignant 1 DCIS grade 2 (cribriform type)
Malignant 2 High grade DCIS (cribriform type)
Malignant 3 High grade DCIS DIN3 (comedo type)
Malignant 4 High grade DCIS
Malignant 5 High grade DCIS with macrocalcifications (comedo type)
Malignant 6 Invasive ductal carcinoma
Ductal Carcinoma in Situ (DCIS); R1: reading 1; R2: reading 2.for patients grouped according to benign or malignant
diagnosis.
Suspicious microcalcifications are shown for 6 cases
in Figure 1a–c (benign cases) and Figure 2a–c (malignant
cases). Specimen radiography showed the presence of
microcalcifications in the biopsy samples obtained by
vacuum-assisted stereotactic breast biopsy (Figures 1
and 2d–f ). A higher magnification of the radiography
image is shown in the 3rd column of Figure 1 and in
Figure 2g–i. Surface renderings of the microcalcifications,
shown in Figure 1 and Figure 2j–l, illustrate the 3D nature
of the micro-CT imaging technique.
Table 1 shows the number of microcalcifications in the
specimens as detected by expert analysis of the specimen
radiographs shown in Figures 1 and 2d–f and the number
detected by micro-CT analysis. Agreement between the
two was determined by regression analysis and is shown
by a Bland-Altman plot (Figure 3). Micro-CT analysis de-
tected more microcalcifications in both benign (p = 0.043)
and malignant cases (p = 0.028). The ratio between the
number of microcalcifications detected by expert analysis
and by micro-CT was 0.278 (95% Confidence Interval
(CI): 0.15–0.41).
Table 2 summarizes the 3D morphological parameters
as averaged for all microcalcifications in each patient.
Compared to microcalcifications in patients diagnosed
with malignant lesions, samples from patients diag-
nosed with benign lesions had a higher average volume
(0.0159 ± 0.0071 mm3 versus 0.0078 ± 0.0095 mm3), a lar-
ger surface area (0.30 ± 0.10 mm2 versus 0.18 ± 0.16 mm2),
a smaller surface area-to-volume ratio (77.68 ± 37.96 mm-1
versus 81.02 ± 19.96 mm-1), were thicker (0.26 ± 0.04 mm
versus 0.19 ± 0.04 mm), and had smaller SMI values
(3.02 ± 0.11 versus 3.05 ± 0.06). Patients diagnosed withe amount of microcalcifications counted by experts and
X-ray X-ray X-ray Micro-CT
Expert 1 Expert 2 Expert 3
R1 R2 R1 R2 R1 R2
22 9 10 24 19 22 64
5 8 8 6 8 7 25
57 35 39 48 39 44 59
18 10 10 10 16 14 15
17 10 10 18 14 18 21
12 9 9 14 12 9 13
27 23 25 36 23 25 29
34 28 29 44 44 46 214
47 31 30 51 49 52 110
27 9 9 26 25 23 27
14 6 6 15 16 16 21
Figure 1 Analysis of microcalcifications in benign tissue. (a-c) Mammograms (cases: benign 1, 2, 3). (d-f) Radiographs of the breast core
biopsies (placed on a dish). (g-i) Higher magnification of the specimen radiograph. (j-l) 3D micro-CT surface rendering of fibrous breast tissue (1),
calcified fibroadenoma (2), and fibrocystic disease (3).
Figure 2 Analysis of microcalcifications in malignant lesion. (a-c) Mammograms (cases: malignant 1, 3, 6). (d-f) Radiographs of the breast
core biopsies (placed on a dish). (g-i) Higher magnification of the specimen radiograph. (j-l) 3D micro-CT surface rendering of DCIS (1, 3) and
invasive ductal carcinoma (6).
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Figure 3 Comparison of the number of microcalcifications detected by expert analysis versus micro-CT by regression analysis (left)
and Bland-Altman plot (right). The dotted lines on the Bland-Altman plot represent the average difference ± 2SD (standard deviation).
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than those with malignant lesion, 69.00 ± 79.39. However,
apart from thickness, none of these differences were
significant.
In addition to calculating the morphological parameters
that describe the microcalcifications in each biopsy
sample, individual object analysis was performed on
microcalcifications that were larger than 2 image voxels
(0.000086 mm3). Table 3 shows the mean and standard
deviation of these individual results and of the number of
objects found in benign and malignant samples classified
according to their volume. The volume threshold was set
at 0.0042 mm3, which corresponds to a microcalcification
that might be visible on mammography, depending on the
contrast. In the mammography images, the pixel size is
0.1 mm, so a microcalcification of 2 pixels corresponds
to a volume of 0.0042 mm3 (slightly less than 100 voxels
in the micro-CT images), assuming perfectly spherical
objects with a diameter of 0.2 mm.Table 2 Overview of the 3D morphological parameters analys
Cases Obj.V (mm3) Obj.S (mm2) Obj.S/Ob
Benign 1 0.0150 0.28 142.86
Benign 2 0.0237 0.37 59.53
Benign 3 0.0203 0.37 51.01
Benign 4 0.0050 0.14 79.07
Benign 5 0.0156 0.34 55.93
Mean ± SD 0.0159 ± 0.0071 0.30 ± 0.10 77.68 ± 3
Malignant 1 0.0269 0.49 84.85
Malignant 2 0.0075 0.20 46.46
Malignant 3 0.0024 0.08 99.66
Malignant 4 0.0041 0.13 77.26
Malignant 5 0.0028 0.10 76.80
Malignant 6 0.0031 0.10 101.12
Mean ± SD 0.0078 ± 0.0095 0.18 ± 0.16 81.02 ± 1
Sign Man-U 0.126 0.126 0.662
Object Volume (Obj.V) in mm3, Object Surface (Obj.S) in mm2, Object Surface/Objec
Model Index (SMI), and Object Number (Obj.N). Bottom row gives the significance oMore microcalcifications (Obj.N) were detected in the
biopsies of patients with breast carcinoma than in the
biopsies of healthy patients, although this difference
was not statistically significant (Table 2). After excluding
microcalcifications smaller than 2 micro-CT voxels and
grouping the remaining calcifications according to volume,
as described above, 73.8% of the calcifications in the
small-sized group were in samples from patients with
malignant lesions, while 59.3% of those in the large-sized
group were in samples from patients with malignant
lesions. In terms of the distribution of all the small calcifi-
cations [(small-sized) + (microcalcifications < 2 micro-CT
voxels)] in samples from malignant cases, 76.8% were small,
while in samples from benign cases, 63.9% were small
(Table 3).
Although the average total volume of the microcalcifi-
cations in the benign versus malignant groups was not
significantly different (Table 2), the data in Table 3 show
that there were more small calcifications in the malignanted as averages over all microcalcifications per patient













9.96 0.19 ± 0.04 3.05 ± 0.06 69.00 ± 79.39
0.017* 1.00 0.662
t Volume (Obj.S/Obj.V) in 1/mm, Structure Thickness (St.Th) in mm, Structure
f group differences.
Table 3 Overview of the individual object analysis results divided in two groups representing lesions with a size on
mammography of 0.2 mm or 2 mammography image pixels
Benign Malignant Test Sign.
P = 0.05
Total Obj.N 182 414
Objects ≤ 0.0042 mm3 (and larger
than 2 micro-CT image voxels)
Obj.V (mm3) 0.0011 ± 0.0010 0.0011 ± 0.0010 T-test ns
Obj.S (mm2) 0.0504 ± 0.0374 0.0515 ± 0.0360 T-test ns
Obj.S/Obj.V (1/mm) 80.00 ± 36.29 73.71 ± 29.43 Independent samples
Mann-Whitney U test
ns
St.Th (mm) 0.0879 ± 0.0277 0.0882 ± 0.0315 T-test ns
SMI 3.13 ± 0.23 3.16 ± 0.2 T-test ns
Obj.N 93 (51%) 262 (63%)
Objects > 0.0042 mm3 Obj.V (mm3) 0.0474 ± 0.0530 0.0152 ± 0.0230 Independent samples
Mann-Whitney U test
s
Obj.S (mm2) 0.8218 ± 0.7996 0.3618 ± 0.3659 Independent samples
Mann-Whitney U test
s
Obj.S/Obj.V (1/mm) 22.86 ± 7.14 29.71 ± 5.71 T-test s
St.Th (mm) 0.2300 ± 0.0658 0.1684 ± 0.0375 T-test s
SMI 3.02 ± 0.27 3.08 ± 0.21 Independent samples
Mann-Whitney U test
ns
Obj.N 65 (36%) 96 (23%)
Object Volume (Obj.V) in mm3, Object Surface (Obj.S) in mm2, Object Surface/Object Volume (Obj.S/Obj.V) in 1/mm, Structure Thickness (St.Th) in mm, Structure
Model Index (SMI), and Object Number (Obj.N). The %-value = percentage of particles of the full amount of benign or malignant particles.
In volume this is represented by a sphere with diameter 0.2 mm: volume = 0.0042 mm3.
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the morphological parameters of the calcifications were
analyzed as averages for all of the subjects in the
two groups, significant differences were observed for
microcalcifications with a volume larger than 0.0042 mm3:
object volumes of 0.0474 ± 0.0530 mm3 in the benign
group versus 0.0152 ± 0.0230 mm3 in the malignant group
(p < 0.001); object surface area of 0.8218 ± 0.7996 mm2
versus 0.3618 ± 0.3659 mm2 (p < 0.001); object surface
area-to-volume ratios of 22.86 ± 7.14 mm-1 versus 29.71 ±
5.71 mm-1 (p < 0.001); thickness of 0.2300 ± 0.0658 mm
versus 0.1684 ± 0.0375 mm (p < 0.001). The SMI values,
3.02 ± 0.27 versus 3.08 ± 0.21 (p = 0.188), were not signifi-
cantly different between the two groups (Table 3).
Discussion
The aim of this study was to analyze the 3D characteristics
of microcalcifications detected by mammography using
micro-CT. Micro-CT is a high-resolution imaging modal-
ity that complements the use of mammography.
The calcifications seen on the mammograms in Figures 1
and 2 had suspicious characteristics, prompting biopsy.
On the specimen radiographs, however, the benign calcifi-
cations seemed brighter and thus easier to detect, which
could be because they are larger, there are more of them,
or because they are denser compared with the calcifica-
tions found in malignant samples. However, the brightness
was not quantified but was based on visual comparison ofthe images. The 3D micro-CT results showed that there
was a significant difference in the size of the calcifications
between the two groups of patients with benign or malig-
nant findings. The results confirmed that the benign calci-
fications were, on average, bigger than the malignant
calcifications, which could lead to better visibility on
the specimen radiographs. The characteristics and num-
ber of microcalcifications is not always clear on clinical
mammograms [40] and specimen radiographs [26]. Table 1
shows that the experts that counted calcifications on
the specimen radiographs underestimated the number
compared to the 3D object analysis using micro-CT.
The underestimation was even greater on the specimen
radiographs when the microcalcifications were orga-
nized in clusters (see Figure 1 to compare patients “Be-
nign 1, 2” with “Benign 3” as the microcalcifications
were more evenly distributed in the latter). Figure 3
confirms this by showing the agreement between the
number of microcalcifications detected with micro-CT and
the number counted by the experts. In the Bland-Altman
plot, the smallest differences are in samples with a small
number of microcalcifications. There is one outlier at the
right bottom side of the plot, which can be explained by
the large difference between the expert’s count and the
count by micro-CT in the sample with the most microcal-
cifications (see Figure 2k “Malignant 3”). This confirms
that it can be difficult to analyze microcalcifications on
projection images. It also emphasizes that 3D imaging of
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the number and the shape and size of calcifications.
Histopathology is still the most sensitive method for
diagnosing breast malignancy and has remained the gold
standard for diagnosing breast carcinoma for a long time
[41]. Invasive ductal carcinoma is the most common
type of breast cancer, making up 70–80% of all breast
cancer diagnoses. The most frequent type of breast
cancer detected in screening is DCIS [3,42], which can
be comedo, cribriform, or micropapillary types. In this
study, 5 of the 11 patients were diagnosed with DCIS.
Comedo carcinoma, which is the most aggressive type,
was found in 2 patients, and 2 other patients were classi-
fied as having the cribriform type. The comedo type of
DCIS is characterized by linear and branching (casting)
calcifications, while calcifications in the cribriform (and
micropapillary) types are more punctate and vary in size
and shape. Among the various parameters used to assess
the diagnostic significance of microcalcifications, irregu-
lar shape is the most indicative of carcinoma, with a pre-
dictive value of 80%; further, 88% of carcinomas with
microcalcifications have irregularly-shaped calcifications
[42]. This preliminary study had no patients with low
grade DCIS. It would be interesting to compare such a
group with benign cases to further evaluate the possible
prognostic power of micro-CT.
As described for the comedo and cribriform types of
DCIS, different pathological entities can give rise to differ-
ent calcification shapes. This also holds true for benign
cases: Fibrocystic changes may give rise to ‘milk of calcium’
or teacup calcifications as seen in Figure 4a and b (bottom
object), or to small calcifications organized in a cluster
(Figure 1 (l)). Fibroadenoma may be associated with large
popcorn-like calcifications (Figure 4a and b, top object).
In terms of malignant lesions, DCIS and invasive duct
carcinoma can be associated with large irregular, rod or
V-shaped, pleomorphic or branching-type calcifications
that follow the distribution of the duct. This is seen clearlyFigure 4 3D models of microcalcifications. (a) 3D model of the larger m
a teacup shape as described in fibrocystic disease. At the top, a popcorn-like s
as in (a) viewed from another direction. (c) Example of a branching v-shapedin Figure 4c. Furthermore, analysis of the characteristics
of the calcifications can help predict tumor size, grade,
and invasiveness [43]. The survival of women with masses
or linear/linear-branching calcifications (i.e., casting calcifi-
cations) is considerably worse than the survival of women
with other types of lesions, suggesting that the calcifications
are associated with duct-forming invasive cancer [44].
Breast tumors associated with casting-type calcifications
by mammography comprise a disease entity that exhibits
substantially more aggressive behavior and poorer outcome
than cancers with other mammographic features [45].
Microcalcifications associated with breast cancer are usu-
ally composed of hydroxyapatite, a bone-specific mineral.
Histological examination of the lesions suggests that the
microcalcifications are breast cancer cells that become
mineralized. In other words, breast microcalcifications can
be considered to be ‘fossils’ of cancer cells [46].
Radiologic-histologic correlations have shown that casting
or rod-like calcifications in the duct are characteristic of
malignancy. Malignant calcifications are typically more
elongated, while benign calcifications are usually more
round [47]. The microcalcification morphologic descriptors
include coarse heterogeneous, amorphous, fine pleomorphic,
and fine linear; these descriptors have a progressively
increasing risk of malignancy [48]. Tables 2 and 3 show that
the SMI values are around 3, indicating that the microcalci-
fications are cylindrical in both benign and malignant cases.
The surface area-to-volume ratio is another important 3D
parameter that describes the shape of an object. We found
that this ratio was higher for the large particles in malig-
nant cases (Table 3); these microcalcifications were point-
ier and rough, as reported in the literature.
In this study, the number of calcifications was not a
relevant parameter for classification purposes, and it is
only described as such in a few articles that seem to have
contradictory results. Franceschi et al. [49] described a
correlation between malignancy and the presence of more
than 15 calcifications on mammography. In this studyicrocalcifications found in “benign 2”. The calcification at the bottom has
hape can be seen as described in fibroadenoma. (b) The same 3D model
microcalcification as a cribriform ductal carcinoma in-situ (“malignant 1”).
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http://www.biomedcentral.com/1471-2407/14/9(Table 1), more than 15 calcifications/patient were seen in
both groups, and the number of calcifications was not
significantly different between the two groups (Table 2).
Le Gal et al. [48] reported that the number of calcifications
was higher in carcinomas, which we confirmed (Table 1,
“Malignant 3 and 4”). For a given size, malignant microcal-
cifications tend to be more irregular, which corresponds to
the most important clinical indications of malignancy i.e.
linear or branching microcalcifications. Table 2, however,
shows that the thickness of the benign calcifications in
our study was significantly greater than in the malignant
group. When we classified the individual microcalcifica-
tions according to their volume, 76.8% vs. 63.9% of the
objects in the malignant and benign groups, respectively,
were small (Table 3). Furthermore, there were 318 vs. 117
small calcifications in the malignant and benign groups,
respectively; this included the smallest calcifications (< 2
image voxels). This relationship between malignancy and
small-sized calcifications was also described by Franceschi
et al. [49] and by Gufler et al. (30]. The latter study used
micro-CT, although it did not focus on 3D volumes and
shapes. The ability to view/detect these small calcifications
is a clear advantage of using the high-resolution micro-CT
system. The appearance of these smaller calcifications
seems to be a feature of malignancy. The thickness and
the object volume were also significantly different, with
the benign group having larger structures than the malig-
nant group. This might be why the physician decided to
perform a biopsy in each of these patients, with the biopsy
showing that these were false positives.
This preliminary study included only a small number
of patients in order to lay the groundwork for a larger
study. The samples are biased, since biopsies are only
taken when malignancy is suspected. According to standard
procedure, the specimen radiographs were not taken for
diagnostic purposes but rather to classify the biopsies for
embedding in paraffin. Therefore the radiograph settings
were not correlated with the micro-CT settings.
Future studies should include more patients, ideally with
different types of benign and malignant calcifications
(including the 3 grades of DCIS) in order to statistically
analyze the differences in the morphological parameters
of these distinct groups. For larger microcalcifications,
the 3D shapes should be characterized in greater detail.
In terms of the smaller calcifications, additional parameters
need to be investigated, such as the separation between
particles as a descriptor for the cluster itself.
Conclusion
Micro-CT shows promise as a valuable tool for under-
standing the morphologic characteristics of malignant and
benign microcalcifications. Radiology and pathology, both
of which are 2D techniques, can benefit from complemen-
tary 3D micro-CT evaluation of microcalcifications. In thispreliminary study, micro-CT images of breast biopsies were
related to the pathological diagnosis. The data showed that
the appearance of many small microcalcifications can be an
indication for malignancy. In larger microcalcifications,
the 3D parameters confirmed the more irregular shape of
malignant samples compared to benign samples.
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